The following are summaries related to new research on various COPD studies and reports.
New Treatment to Combat COPD
A new report published in The FASEB Journal discusses a new drug to fight off the effects of COPD.
The study examined the effectiveness of a receptor type medication which researchers believe could reverse the inflammatory response of COPD by blocking a molecule risk factor.
Researchers found by impeding RAGE (receptor for advanced glycan end products), inflammatory responses up to 20% can reduce COPD flares, and there was reduced airway damage in mice. RAGE has been identified as a risk gene for COPD development.